Gabler, Maximilian
Geier, Silke
Mayerhoff, Lukas
Rathmann, Wolfgang
Article History
Received: 12 November 2020
Accepted: 20 January 2021
First Online: 9 February 2021
Ethics approval and consent to participate
: This paper does not contain any studies with human participants performed by the authors. Anonymized SHI data were used for this research. The use of such data is not subject to ethics committee approval in Germany.The study obtained approval from the internal InGef Scientific Research Group which considers both ethical and scientific aspects of the intended study and has waved the need of informed consent.The study was carried out in accordance with relevant guidelines.
: Not applicable.
: MG is an employee of BI. SG (deceased 02 September 2019) was an employee of BI. LM is a former employee of Elsevier Health Analytics which was paid by BI to conduct the analyses. WR reports receiving consulting fees for attending educational sessions or advisory boards from AstraZeneca, Boehringer Ingelheim and Novo Nordisk and institutional research grants from Novo Nordisk.